The Business AI Briefing
ARPA-H Bets $62.7 Million on the First FDA-Authorized Heart-Failure AI Agent
A 4-year ADVOCATE program aims to deliver a patient-facing agentic AI for heart failure — with an FDA authorization package due in 24 months.
Page 3 of 16. Not sure where to start? Take the free AI assessment.







